On June 19, Meng Jianzhu, former member of the 18th Central Political Bureau and former secretary of the Central Political and Legal Committee, visited the Libang Pharmaceutical Research Institute located in the High-tech Zone Entrepreneurship R&D Park. Ju Jianbo, President of Libang Medical Industry Group, and Libang Chen Tao, dean of the Institute of Medicine, accompanied the visit.
During the period, Meng Jianzhu and his party visited the laboratory and analysis center of Libang Research Institute, and had a cordial conversation with everyone. Ju Jianbo, president of Libang Medical Industry Group, and Chen Tao, president of Libang Pharmaceutical Research Institute, gave detailed introductions on the company's main products, enterprise development status, and new drug research and development.
At the same time, I learned about the company's key products: propofol emulsion injection, alprostadil injection, medium and long-chain fat emulsion injection and the medical device "non-invasive instantaneous continuous blood pressure monitor", and personally tried the newly developed smart glove wearer "Qiaoshou" affirmed the innovative ideas of this product.
Finally, the visiting group unanimously affirmed Libang's achievements in new drug research and development, and encouraged Libang to further explore new development paths for the R&D industry under the influence of a series of new national policies to encourage innovation, so as to achieve faster and better development of the enterprise.
background introduction
Libang Pharmaceutical Research Institute is the scientific research management organization of Xi'an Libang Medical Industry Group Co., Ltd., one of the "Top 100 Pharmaceutical Enterprises". Pharmaceutical Co., Ltd. Research Institute, Xi'an Libang Biomedical Technology Co., Ltd., and Beijing Libang Biomedical Technology Co., Ltd. five scientific research companies. Since its establishment in 2016, it has been equipped with modern instruments and equipment in line with international standards. Relying on independent innovation of science and technology, it has built an innovative drug technology platform, covering all aspects of drug development such as early drug discovery, preclinical research, and pilot production. The successful transformation of research and development into the platform continuously enhances the ability of independent research and development and innovation, and helps Libang Medical Industry Group to achieve new breakthroughs.
On June 19, Meng Jianzhu, former member of the 18th Central Political Bureau and former secretary of the Central Political and Legal Committee, visited the Libang Pharmaceutical Research Institute located in the High-tech Zone Entrepreneurship R&D Park. Ju Jianbo, President of Libang Medical Industry Group, and Libang Chen Tao, dean of the Institute of Medicine, accompanied the visit.
During the period, Meng Jianzhu and his party visited the laboratory and analysis center of Libang Research Institute, and had a cordial conversation with everyone. Ju Jianbo, president of Libang Medical Industry Group, and Chen Tao, president of Libang Pharmaceutical Research Institute, gave detailed introductions on the company's main products, enterprise development status, and new drug research and development.
At the same time, I learned about the company's key products: propofol emulsion injection, alprostadil injection, medium and long-chain fat emulsion injection and the medical device "non-invasive instantaneous continuous blood pressure monitor", and personally tried the newly developed smart glove wearer "Qiaoshou" affirmed the innovative ideas of this product.
Finally, the visiting group unanimously affirmed Libang's achievements in new drug research and development, and encouraged Libang to further explore new development paths for the R&D industry under the influence of a series of new national policies to encourage innovation, so as to achieve faster and better development of the enterprise.
background introduction
Libang Pharmaceutical Research Institute is the scientific research management organization of Xi'an Libang Medical Industry Group Co., Ltd., one of the "Top 100 Pharmaceutical Enterprises". Pharmaceutical Co., Ltd. Research Institute, Xi'an Libang Biomedical Technology Co., Ltd., and Beijing Libang Biomedical Technology Co., Ltd. five scientific research companies. Since its establishment in 2016, it has been equipped with modern instruments and equipment in line with international standards. Relying on independent innovation of science and technology, it has built an innovative drug technology platform, covering all aspects of drug development such as early drug discovery, preclinical research, and pilot production. The successful transformation of research and development into the platform continuously enhances the ability of independent research and development and innovation, and helps Libang Medical Industry Group to achieve new breakthroughs.
